Background
For a hemodynamically unstable patient with a pelvic fracture, the use of preperitoneal or retroperitoneal pelvic packing (PP) is one of the more controversial treatment methods and is evidenced by varying recommendations in guidelines. The Advanced Trauma Life Support guideline [
1] does not include the application of PP, whereas the World Society of Emergency Surgeons (WSES) [
2] states all patients who are hemodynamically unstable should have preperitoneal PP considered for placement first, prior to any other intervention. Evidence of further incongruity is in the Eastern Association for the Surgery of Trauma (EAST) [
3] recommendations, where it suggests the use of retroperitoneal PP only after angiographic embolization, or as part of a multidisciplinary approach with a pelvic orthotic device. Similarly, Western Trauma Association (WTA) [
4] recommends applying preperitoneal PP after angiography or angioembolization if the patient remains hemodynamically unstable and after a negative focused assessment with sonography for trauma (FAST) with consideration for placement of an external fixator. Lastly, the Trauma Quality Improvement Program (TQIP) [
5] guideline states that preperitoneal PP should be used when angiography is unavailable, as well as after a negative FAST, preferably following the application of an external fixation device. Although Cothren et al. [
6] described the development of pelvic packing as a “paradigm shift,” there is little consensus and the recommendations for PP vary by organization and by region.
Owing to the diverse guidelines for the use of PP, the purpose of this study was threefold, to describe: 1) hospital practices on the use of PP at American College of Surgeons (ACS) verified Level 1 trauma centers in the United States, 2) the beliefs of the trauma medical directors on the safety and efficacy of PP, 3) how PP preferences varied by region, annual trauma admissions, and length of time in years as an ACS-verified level 1 trauma center. The study hypothesis was that management practices would vary by region, annual trauma admissions, and years as a level 1 trauma center.
Results
There were 40/158 survey responses, resulting in a response rate of 25%. Of those, 36/40 (90%) completed the survey and 4/40 (10%) partially completed the survey. There were 118/158 (75%) trauma medical directors who did not respond to survey. The partially completed responses were included in the final analysis. The survey took a median (IQR) of 11 min (8-21) to complete.
Table
1 summarizes the trauma center demographics. The most common response for the U.S. Census Bureau region was the South, 40% (16/40), followed by the Midwest, 25% (10/40), the Northeast, 20% (8/40), and the West, 15% (6/40). Ninety percent (36/40) of the participating level 1 trauma centers had a high volume of trauma admissions, defined as > 1500 patients in 2017. Ten percent (4/40) of the participating trauma centers had a low volume of trauma admissions, defined as ≤ 1500 patients admitted in 2017. The majority, 58% (23/40), of participating level 1 trauma centers had been an ACS-verified level 1 trauma center for over 10 years.
U.S Census Bureau Region | Midwest | 25% (10) | 40 |
Northeast | 20% (8) |
South | 40% (16) |
West | 15% (6) |
Number of 2017 trauma admissions | Low-Volume ≤ 1500 | 10% (4) | 40 |
High-Volume 1501–4000 | 90% (36) |
Length of time as Level 1 Trauma Center | < 1 year | 5% (2) | 40 |
> 1 to 2 years | 15% (6) |
> 2 to 5 years | 18% (7) |
> 5 to 10 years | 5% (2) |
> 10 years | 58% (23) |
Organization that developed guideline | EAST | 43% (9) | 21 |
WTA | 29% (6) |
TQIP | 14% (3) |
ATLS | 10% (2) |
Other | 5% (1) |
WSES | 0 |
Pelvic packing used | Yes | 83% (30) | 36 |
No | 17% (6) |
Indicators for pelvic packing | Hemodynamically Unstable | 34% (10) | 29 |
After Ex-Lap | 10% (3) |
After angiography | 3% (1) |
No blush, unstable after Angio | 7% (2) |
IR Unavailable | 17% (5) |
In OR | 3% (1) |
Increasing hematoma in OR | 3% (1) |
Last resort | 10% (3) |
Physicians judgement | 10% (3) |
Type of pelvic packing used | Retroperitoneal | 3% (1) | 30 |
Preperitoneal | 53% (16) |
Both | 43% (13) |
Pelvic packing used only as a last resort | Yes | 47% (14) | 30 |
No | 53% (16) |
Pelvic packing used on all hemodynamically unstable patients | Yes | 13% (2) | 16 |
No | 88% (14) |
Pelvic packing is a treatment option for hemodynamically stable patients | Yes | 6% (1) | 16 |
Sometimes | 50% (8) |
No | 44% (7) |
Pelvic packing is a safe treatment method | Yes | 72% (26) | 36 |
Sometimes | 25% (9) |
No | 3% (1) |
Pelvic packing is an effective treatment method | Yes | 33% (12) | 36 |
Sometimes | 64% (23) |
No | 3% (1) |
Pelvic packing increases risk for infection | Yes | 44% (16) | 36 |
No | 56% (20) |
The benefits of pelvic packing outweigh the risks | Yes | 94% (15) | 16 |
No | 6% (1) |
The top two guidelines followed were: EAST, 43% (9/21) and WTA, 29% (6/21). No participants followed the WSES guideline. Pelvic packing was reported as a treatment method utilized at 83% (30/36) of the level 1 trauma centers. Only 3 % (1/36) of level 1 trauma centers utilized solely retroperitoneal PP, 53% (16/30) used preperitoneal PP only, and 43% (13/30) used both retroperitoneal and preperitoneal PP.
Trauma medical directors were asked their anecdotal beliefs on the safety, effectiveness, risk of infection, and if the benefits of PP outweighed the risks for infection. The majority of participants, 72% (26/36), perceived that PP was a “safe” treatment method, 25% (9/36) perceived that PP was “sometimes safe”, and one participant perceived that PP was “not safe”. With regard to the perceived effectiveness of PP, 33% (12/36) of the participants perceived that PP was “effective”, 64% (23/36) of participants perceived that PP was “sometimes” an effective treatment method and one perceived that PP was “not effective”. Participants were split when asked if PP increased the risk for infection, 44% (16/36) of participants perceived PP increased the risks for infection and 56% (20/36) perceived PP did not increase the risks for infection. Only one participant did not perceive that the benefits of PP outweighed the risks for infection.
Participants were queried to determine the priority of each treatment management technique for hemodynamically unstable patients; Table
2 summarizes their responses. Although there was strong agreement reported on a preference towards utilization of circumferential compression devices as the first priority treatment method, there was less agreement on the second priority treatment method; there was a near three-way tie between the use of resuscitative endovascular balloon occlusion of the aorta (REBOA), angiography, and exploratory laparotomy. Most of the participants reported that their trauma center utilized PP as the third 36% (9/25,) or fourth 40% (10/25) priority treatment method. Exploratory laparotomy and external fixation device were reported high as the fifth priority treatment utilized for hemodynamically unstable pelvic fractures. Finally, REBOA was the most reported sixth priority treatment utilized.
Table 2
Sequence of treatment methods for pelvic fracture management
CCD | 89% | 0% | 7% | 4% | 0% | 0% |
REBOA | 0% | 33% | 13% | 20% | 7% | 27% |
PP | 0% | 12% | 36% | 40% | 8% | 4% |
Angiography | 11% | 30% | 30% | 22% | 4% | 4% |
Exploratory Laparotomy | 0% | 30% | 15% | 5% | 35% | 15% |
External Fixation Device | 0% | 22% | 13% | 22% | 30% | 13% |
Notwithstanding the consensus on the reported application of PP as a middle priority treatment for hemodynamically unstable pelvic fractures, the indications for its use varied (Table
1). The two most common indications for PP were hemodynamic instability and the unavailability of interventional radiology.
The application of PP to all hemodynamically unstable patients significantly differed by region, Table
3. Northeast and West level 1 trauma centers were more likely than Midwest and South level 1 trauma centers to report that their trauma center applied PP to all hemodynamically unstable pelvic fractures (
p = 0.05). Midwest, South, and West level 1 trauma centers were more likely to perceive that PP was “safe” or “sometimes safe”, whereas Northeast level 1 trauma centers were more likely to perceive that PP was “sometimes safe” or “not safe” (
p = 0.04). Although more regions perceived PP as more safe than unsafe, there was a less positive response when asked if PP was effective. In every region, the number of participants responding that PP was safe was double that when asked if PP is effective.
Table 3
Regional analysis of pelvic packing practices
Is PP used? |
Yes | 80% (8/10) | 57% (4/7) | 92% (12/13) | 100% (6) | 36 | 0.18 |
No | 20% (2/10) | 43% (3/7) | 8% (1/13) | 0% (0) |
Type of PP used |
Use PPP only | 75% (6/8) | 50% (2/4) | 33% (4/12) | 667% (4/6) | 30 | 0.16 |
Use RPP only | 13% (1/8) | 0% (0) | 0% (0) | 0% (0) |
Use both | 13% (1/8) | 50% (2/4) | 67% (8/12) | 33% (2/6) |
Use PP only as a last resort |
Yes | 38% (3/8) | 75% (3/4) | 42% (5/12) | 50% (3/6) | 30 | 0.75 |
No | 63% (5/8) | 25% (1/4) | 58% (7/12) | 50% (3/6) |
Apply PP to ALL hemodynamically Unstable Patients |
Yes | 0% (0) | 100% (1) | 0% (0) | 33% (1/3) | 16 | 0.05 |
No | 100% (5) | 0% (0) | 100% (7) | 67% (2/3) |
PP is an option for hemodynamically Stable Patients |
Yes | 0% (0) | 0% (0) | 15% (1/7) | 0% (0) | 16 | 0.10 |
Sometimes | 40% (2/5) | 100% (1) | 71% (5/7) | 0% (0) |
No | 60% (3/5) | 0% (0) | 14% (1/7) | 100% (3) |
PP is safe |
Yes | 80% (8/10) | 29% (2/7) | 92% (12/13) | 67% (4/6) | 36 | 0.04 |
Sometimes | 20% (2/10) | 57% (4/7) | 8% (1/13) | 33% (2/6) |
No | 0% (0) | 14% (1/7) | 0% (0) | 0% (0) |
PP is effective |
Yes | 40% (4/10) | 14% (1/7) | 38% (5/13) | 33% (2/6) | 36 | 0.68 |
Sometimes | 60% (6/10) | 71% (5/7) | 62% (8/13) | 67% (4/6) |
No | 0% (0) | 14% (1/7) | 0% (0) | 0% (0) |
PP increases the risk for infection |
Yes | 50% (5/10) | 44% (3/7) | 23% (3/13) | 83% (5/6) | 36 | 0.11 |
No | 50% (5/10) | 57% (4/7) | 77% (10/13) | 17% (1/6) |
PP benefits outweigh the risks |
Yes | 80% (4/5) | 100% (3) | 100% (3) | 100% (5) | 16 | 0.99 |
No | 20% (1/5) | 0% (0) | 0% (0) | 0% (0) |
The relationship between 2017 volume of trauma admissions and PP practices can be seen in Table
4. Seventy-five percent (3/4) of the low-volume level 1 trauma centers utilized PP as a treatment modality and 84% (27/32) of the high-volume level 1 trauma centers utilized PP (
p = 0.53). All the low-volume level 1 trauma centers that used PP, applied PP only as a last resort to control hemorrhage (4/4); whereas of the high-volume level 1 trauma centers that use PP, 41% (11/27) utilized PP only as a last resort to control hemorrhage (
p = 0.09). All the low-volume trauma center’s participants perceived that PP placed the patient at an increased risk for infection, whereas 38% (12/32) high-volume trauma center’s participants perceived that PP placed the patient at an increased risk for infection (
p = 0.03). However, all the participants at low-volume level 1 trauma centers and 92% (11/12) of the participants at high-volume level 1 trauma centers perceived that the benefits of PP outweighed the risk for infection.
Table 4
Analysis of hospital volume and pelvic packing practices
Is PP used? |
Yes | 84% (27/32) | 75% (3/4) | 36 | 0.53 |
No | 16% (5/32) | 25% (1/4) |
Type of PP used |
Use PPP only | 56% (15/27) | 33% (1/3) | 30 | 0.62 |
Use RPP only | 3.7% (1/27) | 0% (0) |
Use both | 41% (11/27) | 67% (2/3) |
Use PP only as a last resort |
Yes | 41% (11/27) | 100% (3) | 30 | 0.09 |
No | 59% (16/27) | 0% (0) |
Apply PP to ALL hemodynamically unstable patients |
Yes | 12% (2/16) | 0% (0) | 16 | N/A |
No | 88% (14/16) | 0% (0) |
PP is an option for hemodynamically stable patients |
Yes | 6% (1/16) | 0% (0) | 16 | N/A |
Sometimes | 50% (8/16) | 0% (0) |
No | 44% (7/16) | 0% (0) |
PP is safe |
Yes | 75% (24/32) | 50% (2/4) | 36 | 0.35 |
Sometimes | 22% (7/32) | 50% (2/4) |
No | 3% (1/32) | 0% (0) |
PP is effective |
Yes | 38% (12/32) | 0% (0) | 36 | 0.36 |
Sometimes | 59% (19/32) | 100% (4) |
No | 3% (1/32) | 0% (0) |
PP increases the risk for infection |
Yes | 38% (12/32) | 100% (4) | 36 | 0.03 |
No | 63% (20/32) | 0% (0) |
PP benefits outweigh the risks |
Yes | 92% (11/12) | 100% (4) | 16 | 0.99 |
No | 8% (1/12) | 0% (0) |
Table
5 shows how PP practices varied across level 1 trauma centers when categorized by the length of time the trauma center has been designated an ACS-verified Level 1 trauma center. Two (18.18%) level 1 trauma centers that had been designated a level 1 trauma center for ≥10 years reported a preference towards application of PP to all hemodynamically unstable patients, no other level 1 trauma centers reported a preference towards application of PP to all hemodynamically unstable patients. Overall, we observed a lack of significant association between the length of time since the participating level 1 trauma centers received their respective level 1 trauma center designation and all participant responses.
Table 5
Pelvic packing and length of time in years as an ACS-verified level 1 trauma center
PP is used |
Yes | 100% (2) | 60% (3/5) | 71% (5/7) | 50% (1/2) | 95% (19/20) | 36 | 0.10 |
No | 0% (0) | 40% (2/5) | 29% (2/7) | 50% (1/2) | 5% (1/20) |
Type of PP used |
PPP only | 50% (1/2) | 67% (2/3) | 60% (3/5) | 0% (0) | 53% (10/19) | 30 | 0.97 |
RPP only | 0% (0) | 0% (0) | 0% (0) | 0% (0) | 5% (1/19) |
Both | 50% (1/2) | 33% (1/3) | 40% (2/5) | 100% (1) | 42% (8/19) |
Use PP only as a last resort |
Yes | 50% (1/2) | 33% (1/3) | 60% (3/5) | 100% (1) | 42% (8/19) | 30 | 0.85 |
No | 50% (1/2) | 67% (2/3) | 40% (2/5) | 0% (0) | 58% (11/19) |
Apply PP to all hemodynamic unstable patients |
Yes | 0% (0) | 0% (0) | 0% (0) | 0% (0) | 18% (2/11) | 16 | 0.99 |
No | 100% (1) | 100% (2) | 100% (2) | 0% (0) | 82% (9/11) |
PP is an option for hemodynamic stable patients |
Yes | 0% (0) | 0% (0) | 0% (0) | 0% (0) | 9% (1/11) | 16 | 0.8 |
Sometimes | 0% (0) | 100% (2) | 50% (1/2) | 0% (0) | 45% (5/11) |
No | 100% (1) | 0% (0) | 50% (1/2) | 0% (0) | 45% (5/11) |
PP is safe |
Yes | 100% (2) | 80% (4/5) | 71% (5/7) | 0% (0) | 75% (15/20) | 36 | 0.2 |
Sometimes | 0% (0) | 20% (1/5) | 14% (1/7) | 100% (2) | 25% (5/20) |
No | 0% (0) | 0% (0) | 14% (1/7) | 0% (0) | 0% (0) |
PP is effective |
Yes | 0% (0) | 40% (2/5) | 14% (1/7) | 0% (0) | 45% (9/20) | 36 | 0.44 |
Sometimes | 100% (2) | 60% (3/5) | 71% (5/7) | 100% (2) | 55% (11/20) |
No | 0% (0) | 0% (0) | 14% (1/7) | 0% (0) | 0% (0) |
PP increases the risk of infection |
Yes | 100% (2) | 20% (1/5) | 43% (3/7) | 50% (1/2) | 45% (9/20) | 36 | 0.57 |
No | 0% (0) | 80% (4/5) | 57% (4/7) | 50% (1/2) | 55% (11/20) |
PP benefits outweigh the risks |
Yes | 100% (2) | 100% (1) | 67% (2/3) | 100% (1) | 100% (9) | 16 | 0.44 |
No | 0% (0) | 0% (0) | 33% (1/3) | 0% (0) | 0% (0) |
Discussion
Most published guidelines recommend the use of PP for hemodynamically unstable patients. However, when following the WTA [
4] algorithm, PP is also an option for hemodynamically stable patients in two scenarios: 1) after a pelvic blush is seen during angiography and unsuccessful angioembolization or 2) for a hemodynamically stable patient who is admitted to the ICU and then has an unsuccessful angioembolization. One participant responded that PP is “an option” for hemodynamically stable patients and seven participants surveyed stated that PP is “sometimes an option” for hemodynamically stable patients but none of those participants were following the WTA guideline. Since the early description of PP application, it has conventionally been applied to hemodynamically unstable patients, typically in extremis.
When PP was first used, it was applied for damage control using the transperitoneal approach by making an incision in the intact peritoneum disrupting the pelvic hematoma, and it was commonly used as a last course of resuscitation in patients who were coagulopathic [
9‐
12]. These practices resulted in poor patient outcomes and many physicians abandoned the use of PP. The findings of this study indicate that roughly half of participants applied PP only as a last resort for hemorrhage control. This may explain why 67% of participants perceived that PP is “sometimes” or “not effective”. The techniques for PP application have since evolved and currently no guidelines recommend the application of PP as a last resort to control hemorrhage. In fact, the WSES [
2] states that all hemodynamically unstable patients should have PP considered prior to any other intervention.
There is a lack of consensus in the literature on when to apply PP and the sequence of treatment methods; this is reflected by the variation in survey responses. The most common indicator for PP reported was hemodynamic instability, yet only two participants reported that PP is applied to all hemodynamically unstable patients at their trauma center. Whereas, the WSES [
2] guideline recommends considering PP as the first-line of treatment for all hemodynamically unstable patients. A majority of participating level 1 trauma centers reported PP was utilized as the third or fourth priority treatment for hemodynamically unstable pelvic fractures. The TQIP [
5] recommends to apply PP in two different scenarios for hemodynamically unstable patients, as the second or third priority treatment. The WTA [
4] also applies PP in two scenarios for hemodynamically unstable patients, as the second or third priority treatment. The EAST [
3] guideline uses PP as the third priority treatment. The guidelines recommend earlier application of PP, as the first, second, or third priority treatment; whereas our survey results show that level 1 trauma centers applied PP later in the treatment course, as the third or fourth priority treatment. For more information on the guideline’s treatment sequence see Table
6.
Table 6
Sequence of treatment methods in published guidelines for hemodynamically unstable patients
First | PP | CCD | CCD | REBOA | CCD | CCD | CCD | CCD |
Second | CCD, REBOA, and / or Angio | Ex-Lap | Ex-Fix | PP | Ex-Fix, REBOA, or PP | Ex-Lap & Ex-Fix | Angio | Ex-Lap or Angio |
Third | Ex-Lap | Consider Ex-fix | PP | Ex-Lap | PP or Angio | PP | PP | Ex-Fix |
Fourth | Re-angio | | Angio | Ex-Fix | Angio | Angio | | |
Fifth | Ex-Fix | | | Angio | | | | |
Among the ranked second-line of treatment methods appeared REBOA. Brenner et al. [
13] issued a joint policy statement addressing the current practices of REBOA. They stated there is currently no high-grade evidence that demonstrates REBOA improved outcomes or survival compared to standard treatment of severe hemorrhage. In addition, they state that the benefits of REBOA are unproven. Despite this, most of those that reported their trauma center utilized REBOA, utilized it earlier than other approaches for hemodynamically unstable pelvic fractures. In 2017, Stahel et al. [
14] conducted a literature review and reported that REBOA could effectively bridge the time to the operating room until definitive surgical bleeding control, but that future validation studies are needed to determine its use in the multidisciplinary management of pelvic fractures.
Most of the guidelines recommending the application of PP, state to use the
preperitoneal method; only the EAST guideline [
3] recommends the use of the
retroperitoneal method. However, within the EAST guideline’s scientific foundation section for
retroperitoneal PP, EAST ironically only includes literature on
preperitoneal PP. This may be the cause of the variations in practice in the current findings. Although the most common response for what guideline the trauma center was following was the EAST guideline, only a couple of level 1 trauma centers following the EAST guideline stated they used both retroperitoneal and preperitoneal PP, and none stated they used solely retroperitoneal PP. Smith et al. [
15] described the surgical technique for
retroperitoneal pelvic packing in 2005. They state during the
retroperitoneal approach, an 8-cm midline incision from the symphysis pubis in the caudal direction is made, skin and subcutaneous tissue are incised, and the fascia is divided in the midline. The pelvic brim is palpated, and laparotomy sponges are placed as deep to the brim as possible in the true pelvis. In 2007, Cothren et al. [
6] published the first epidemiological study assessing outcomes in patients after modifying the technique for PP application by transitioning from applying PP to the
retroperitoneum, to directly packing the pelvis using a
preperitoneal approach addressing venous and bone hemorrhage without disrupting the pelvic hematoma. They described the surgical technique for the
preperitoneal approach as a 6- to 8-cm midline incision made from the public symphysis in the cephalad direction. The midline fascia is also divided using the
preperitoneal approach, but the peritoneum is left intact.
Preperitoneal PP is applied to each side of the bladder into the pelvis below the pelvic brim. The Cothren et al. article on
preperitoneal PP, as well as other articles on
preperitoneal PP, were cited in the EAST guideline as evidence for application of
retroperitoneal pelvic packing.
The safety and effectiveness of PP remains controversial; there was incongruence in participant’s responses when asked if PP was an effective treatment method to control pelvic hemorrhage. Only a third of participants perceived that PP was effective. Marzi et al. [
16] conducted a literature review on pelvic fracture management in 2009 and concluded that pelvic packing should be used for hemodynamically unstable patients who do not respond to resuscitative fluids and those requiring continuous fluids to maintain hemodynamic stability. Many studies [
9,
11,
16‐
18] have compared PP to angioembolization as a treatment modality, leading to some [
4,
15,
19‐
21] concluding that that the two approaches should not be compared and should instead be viewed as complementary. In 2018, Muntasar et al. [
9] found insufficient evidence to support superiority of one treatment modality over the other. Cothren et al. [
6] observed a reduction in their own mortality rate in patients with pelvic fractures, from roughly 50 to 25%, after adopting an algorithm using PP. Although, trauma medical directors did not agree on the effectiveness of PP, a majority of the trauma medical directors perceived that PP was a “safe” treatment method or “sometimes safe”; only one trauma medical director perceived that PP was “not safe”.
The main complication of PP reported is pelvic space infections, which may be a contributing factor to the finding that over a quarter of participants perceived that PP was “not safe” or “sometimes safe”. Burlew et al. found [
19] that 6% of patients with PP developed infections, and 47% of patients who required repacking developed pelvic space infections. In another study conducted by Burlew et al. [
21], 12% of patients with preperitoneal PP developed pelvic space infections. Totterman et al. [
12] reported a pelvic infection rate of 33% after PP. None of these studies compared infection rates between PP and other pelvic fracture treatment modalities. Li et al. [
17] and Osborn et al. [
22] compared the infection rates between patients who had PP applied to patients who had angiography or angioembolization and found no significant difference in infection rates. Our findings indicate a lack of consensus on participants’ beliefs regarding the risk for infection. Approximately half of the trauma medical directors perceived that PP increased the risks for infection, only one trauma medical director perceived that the benefits of PP did not outweigh the risks of infection.
Limitations
The results of this study are limited by the response rate of 25% (40/158); there were 118/158 (75%) trauma medical directors who did not participate. Contacting the participants proved difficult as contact information was not always accurate. This resulted in delayed contact with the participants, fewer reminders being sent, and a shortened response time. The survey responses represented the perspective of the responding trauma medical director and were not independently verified. Trauma medical directors’ responses regarding current protocols and guidelines may have been based on their memory, not referring to actual trauma center protocols, and subject to biases such as selective memory, telescoping, attribution, and exaggeration. The survey instructions informed trauma medical directors to have the guideline or protocol on-hand twice, in the invitation and upon opening the survey, to reduce the effect of self-reported data bias. Although the survey was anonymous, the study could reveal a level of inefficiency and unpreparedness in face of complex trauma patients, further limiting the response rate. Survey accessibility was also a limitation. The study protocol was approved for SurveyMonkey® distribution, limiting those who preferred paper surveys, noted in reminder phone calls. One trauma medical director did not receive the survey due to hospital server restrictions.